Allurion Technologies, Inc. Foreign Currency Transaction Loss, before Tax
Allurion Technologies, Inc. (ALUR) reported Foreign Currency Transaction Loss, before Tax of $253.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2023-11-14
- Allurion Technologies, Inc. foreign currency transaction loss, before tax for the quarter ending 2023-09-30 was $204.00K, a 47.83% increase year-over-year.
- Allurion Technologies, Inc. foreign currency transaction loss, before tax for the quarter ending 2022-09-30 was $138.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month |
|---|---|---|---|
| 2023-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $253.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $49.00K 10-Q · filed 2023-10-20 | ||
| 2022-09-30 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $389.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $251.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |